All our latest news
News
April 30, 2023
Introduction: Meet the New CEO of Crux Biolabs
Discover the vision and goals of Crux Biolabs' new CEO in our in-depth interview. Learn about their background in the pharmaceutical industry and the company's plans for expanding bioanalytical services in Australia's R&D landscape.Read more
News
March 9, 2023
MesoScale Discovery (MSD) assays at Crux Biolabs
MesoScale Discovery (MSD) immunoassays are used to measure the concentration of proteins or other molecules in biological samples. They detect multiple analytes in a single sample and are superior to Luminex because of a wider dynamic range, reduce matrix effects and increase sensitivity. MSD assays…Read more
News
February 20, 2023
The importance of Good Clinical Practice
When it comes to clinical trials, it is all about the patient! Good Clinical Practice – or GCP as it is known - is a must for biolabs to ensure that their clinical trials are conducted ethically and scientifically. This…Read more
News
January 16, 2023
More on the Australian advantage: up to 43.5% cash back for every $1 spent on R&D in Australia
When it comes to places to conduct research, few places globally offer better incentives than Australia. Known as the “Australian advantage”, not only does the land down under offer a fast and pragmatic regulatory environment for clinical studies (with a…Read more
News
January 16, 2023
21 colour flow cytometry with Crux Biolabs
As so many of our partners have thrilled since earlier in the year when we launched our capability to provide 21 colour flow cytometry, we just had to do a shout out to it. As you no doubt know, flow…Read more
News
December 16, 2022
Crux Biolabs: expansion into chemistry
After repeated inquiries from our customer base, Crux Biolabs are pleased to announce their expansion into chemistry analytical services in 2023. These services will be centred around UHPLC and LCMS instrumentation to be installed in our new, purpose-built lab space.…Read more
News
October 15, 2022
Join us at: AusBiotech 2022
We are pleased to be attending AusBiotech 2022 in Perth! If you are also attending this year's event, get in touch with any of our team here as we would love to connect and get to know you better.Read more
News
August 4, 2022
Media Release: Genesis Capital invests in Crux Biolabs
Genesis Capital invests in Crux Biolabs, a leading bioanalytical laboratory to the clinical trials sector Crux Biolabs is a decade-old Australian leader in bioanalytics, customised biomarker detection, cell assay development, clinical and pre-clinical testing with particular strength in the immuno-oncology…Read more
News
June 29, 2022
External Quality Assurance Programs
Crux Biolabs has recently passed 2 External Quality Assurance Programs (EQAPs) and we’d like to congratulate the fantastic scientists involved. Livleen Kaur successfully passed Crux’s 2nd consecutive participation in the international Duke University EQAPOL for Luminex with a staggering score…Read more
Available Positions, News
June 1, 2022
Senior Immunology Scientist hiring (flow cytometry)
We're hiring again! Are you a gun at flow cytometry?Are you sick of short-term academic contracts?Maybe you could be Crux's Senior Immunology Scientist, a newly created permanent position, in our growing contract research team to work on cutting-edge immunotherapy clinical…Read more